Image courtesy by QUE.com Understanding Frontier AI in Cybersecurity As the capabilities of artificial intelligence (AI) ...

Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ligand-conjugated vectors, today announces it will deliver two poster presentations at ...

Artificial intelligence may still be on an upward trajectory, but 2026 is shaping up to be a critical turning point. In this ...

Coca-Cola (NYSE: KO) is one of the most famous long-term investment stories in history, starting with Warren Buffett.

B for Kelonia adds a credible in vivo CAR-T platform aimed at multiple myeloma, with a one-time IV delivery and no ...

In recent years, artificial intelligence has become more accessible than ever before. Powerful libraries, automated platforms ...

Eli Lilly will acquire Kelonia Therapeutics for up to $7bn, securing its lentiviral-based in vivo CAR-T platform and oncology pipeline. The move follows Lilly’s $2.4bn purchase of Orna Therapeutics, ...

At MWC 2026, Huawei released its AIDP. This platform integrates a knowledge base, KV cache acceleration, and a memory bank, and uses the Unified Cache Manager (UCM) to manage and schedule inference ...

The company is moving toward deployment in active conflict environments, including Ukraine, one of the most electronically contested battlefields in the world. Last month, the company announced the ...

Discover how AI models like Claude Sonnet 4.5 utilize 'emotional coding' to simulate moods in responses, impacting user ...

The Permanent Representative of Fiji to the United Nations in New York and Chair of the Pacific Small Island Developing ...

As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.